---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-012078"
form_type: "8-K/A"
ticker: "LBRA"
cik: "0001599407"
company_name: "1847 Holdings LLC"
filed_at: "2024-02-09T23:59:59+00:00"
generated_at: "2026-06-06T04:50:55.499733+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# 1847 Holdings restates ICU Eyewear FY2022/2021 financials; net loss reduced $3.6M

## Summary
- 2022 net loss restated from ($4.62M) to ($1.00M), driven by $3.62M impairment correction.
- 2021 total assets reduced by $2.98M due to restatement; accumulated deficit increased to ($31.43M).
- ICU Eyewear FY2022 revenue $20.45M (2021: $22.03M including PPE); gross profit $6.39M.
- Restatement corrects revenue recognition errors (customer allowances, chargebacks) under ASC 606.

## SEC filing metadata
- accession: 0001213900-24-012078
- form_type: 8-K/A
- ticker: LBRA
- cik: 0001599407
- company_name: 1847 Holdings LLC
- filed_at: 2024-02-09T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1599407/000121390024012078/0001213900-24-012078-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1599407/000121390024012078/ea193214-8ka2_1847hold.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-012078
- JSON: https://secwatch.observer/filing/0001213900-24-012078.json
- Plain text: https://secwatch.observer/filing/0001213900-24-012078.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.